Comparison of TNFα to Lipopolysaccharide as an Inflammagen to Characterize the Idiosyncratic Hepatotoxicity Potential of Drugs: Trovafloxacin as an Example

Idiosyncratic drug reactions (IDRs) are poorly understood, unpredictable, and not detected in preclinical studies. Although the cause of these reactions is likely multi-factorial, one hypothesis is that an underlying inflammatory state lowers the tolerance to a xenobiotic. Previously used in an inflammation IDR model, bacterial lipopolysaccharide (LPS) is heterogeneous in nature, making development of standardized testing protocols difficult. Here, the use of rat tumor necrosis factor-α (TNFα) to replace LPS as an inflammatory stimulus was investigated. Sprague-Dawley rats were treated with separate preparations of LPS or TNFα, and hepatic transcriptomic effects were compared. TNFα showed enhanced consistency at the transcriptomic level compared to LPS. TNFα and LPS regulated similar biochemical pathways, although LPS was associated with more robust inflammatory signaling than TNFα. Rats were then codosed with TNFα and trovafloxacin (TVX), an IDR-associated drug, and evaluated by liver histopathology, clinical chemistry, and gene expression analysis. TNFα/TVX induced unique gene expression changes that clustered separately from TNFα/levofloxacin, a drug not associated with IDRs. TNFα/TVX cotreatment led to autoinduction of TNFα resulting in potentiation of underlying gene expression stress signals. Comparison of TNFα/TVX and LPS/TVX gene expression profiles revealed similarities in the regulation of biochemical pathways. In conclusion, TNFα could be used in lieu of LPS as an inflammatory stimulus in this model of IDRs.

[1]  D. Adams,et al.  Mechanisms of immune-mediated liver injury. , 2010, Toxicological Sciences.

[2]  P. Ganey,et al.  Intrinsic versus Idiosyncratic Drug-Induced Hepatotoxicity—Two Villains or One? , 2010, Journal of Pharmacology and Experimental Therapeutics.

[3]  P. Ganey,et al.  Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  A. D. Jones,et al.  Sulindac Metabolism and Synergy with Tumor Necrosis Factor-α in a Drug-Inflammation Interaction Model of Idiosyncratic Liver Injury , 2009, Journal of Pharmacology and Experimental Therapeutics.

[5]  J. Luyendyk,et al.  Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models , 2009, Pharmacological Reviews.

[6]  P. Ganey,et al.  Trovafloxacin Enhances the Inflammatory Response to a Gram-Negative or a Gram-Positive Bacterial Stimulus, Resulting in Neutrophil-Dependent Liver Injury in Mice , 2009, Journal of Pharmacology and Experimental Therapeutics.

[7]  J. Waring,et al.  Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. , 2009, Toxicology letters.

[8]  P. Muriel NF‐κB in liver diseases: a target for drug therapy , 2009, Journal of applied toxicology : JAT.

[9]  P. Ganey,et al.  Tumor Necrosis Factorα Is a Proximal Mediator of Synergistic Hepatotoxicity from Trovafloxacin/Lipopolysaccharide Coexposure , 2009, Journal of Pharmacology and Experimental Therapeutics.

[10]  J. Waring,et al.  Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  C. de Castro,et al.  Lipopolysaccharide structures from Agrobacterium and Rhizobiaceae species. , 2008, Carbohydrate research.

[12]  Philip R. Cohen,et al.  TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNFα in LPS-stimulated macrophages , 2008, Journal of Cell Science.

[13]  J. Bradley,et al.  TNF‐mediated inflammatory disease , 2008, The Journal of pathology.

[14]  P. Ganey,et al.  Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  J. Mitchell,et al.  Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. , 2007, The Journal of endocrinology.

[16]  M. Lennartz,et al.  Francisella tularensis LVS grown in macrophages has reduced ability to stimulate the secretion of inflammatory cytokines by macrophages in vitro. , 2006, Microbial pathogenesis.

[17]  Michael J Liguori,et al.  Modest Inflammation Enhances Diclofenac Hepatotoxicity in Rats: Role of Neutrophils and Bacterial Translocation , 2006, Journal of Pharmacology and Experimental Therapeutics.

[18]  Michael J Liguori,et al.  Investigations toward enhanced understanding of hepatic idiosyncratic drug reactions , 2006, Expert opinion on drug metabolism & toxicology.

[19]  L. O’Neill,et al.  Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. , 2006, Biochemical pharmacology.

[20]  R. Snyder,et al.  Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database. , 2006, Pharmacogenomics.

[21]  G. Ruthel,et al.  Anthrax Lethal Toxin Impairs Innate Immune Functions of Alveolar Macrophages and Facilitates Bacillus anthracis Survival , 2006, Infection and Immunity.

[22]  J. Luyendyk,et al.  Unique gene expression and hepatocellular injury in the lipopolysaccharide-ranitidine drug idiosyncrasy rat model: comparison with famotidine. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  J. Waring,et al.  Microarray Analysis of Lipopolysaccharide Potentiation of Trovafloxacin-Induced Liver Injury in Rats Suggests a Role for Proinflammatory Chemokines and Neutrophils , 2006, Journal of Pharmacology and Experimental Therapeutics.

[24]  Zhijian J. Chen,et al.  TRAF2: A Double-Edged Sword? , 2005, Science's STKE.

[25]  B. Pulendran Modulating vaccine responses with dendritic cells and Toll‐like receptors , 2004, Immunological reviews.

[26]  J. Luyendyk,et al.  Ranitidine Treatment during a Modest Inflammatory Response Precipitates Idiosyncrasy-Like Liver Injury in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[27]  S. Janssens,et al.  Role of Toll-Like Receptors in Pathogen Recognition , 2003, Clinical Microbiology Reviews.

[28]  R. Stahlmann Clinical toxicological aspects of fluoroquinolones. , 2002, Toxicology letters.

[29]  S. Bursian,et al.  Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy? , 2002, The Journal of pharmacology and experimental therapeutics.

[30]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[31]  P. Libby,et al.  Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. , 1999, The Journal of clinical investigation.

[32]  P. Nettesheim,et al.  Tumor necrosis factor-alpha modulates the expression of its p60 receptor and several cytokines in rat tracheal epithelial cells. , 1996, Journal of immunology.

[33]  D. Kufe,et al.  Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor. , 1990, Cancer research.

[34]  J Horiguchi,et al.  Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. , 1987, Proceedings of the National Academy of Sciences of the United States of America.